TAU syndrome

Common Name(s)

TAU syndrome

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "TAU syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "TAU syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "TAU syndrome" returned 11 free, full-text research articles on human participants. First 3 results:

Altered regulation of tau phosphorylation in a mouse model of down syndrome aging.
 

Author(s): Olivia Sheppard, Florian Plattner, Anna Rubin, Amy Slender, Jacqueline M Linehan, Sebastian Brandner, Victor L J Tybulewicz, Elizabeth M C Fisher, Frances K Wiseman

Journal: Neurobiol. Aging. 2012 Apr;33(4):828.e31-44.

 

Down syndrome (DS) results from trisomy of human chromosome 21 (Hsa21) and is associated with an increased risk of Alzheimer's disease (AD). Here, using the unique transchromosomic Tc1 mouse model of DS we investigate the influence of trisomy of Hsa21 on the protein tau, which is ...

Last Updated: 14 Feb 2012

Go To URL
Positron emission tomography of brain β-amyloid and τ levels in adults with Down syndrome.
 

Author(s): Linda D Nelson, Prabha Siddarth, Vladimir Kepe, Kevin E Scheibel, S C Huang, Jorge R Barrio, Gary W Small

Journal: Arch. Neurol.. 2011 Jun;68(6):768-74.

 

To determine the neuropathological load in the living brain of nondemented adults with Down syndrome using positron emission tomography with 2-(1-{6-[(2-fluorine 18-labeled fluoroethyl)methylamino]-2-napthyl}ethylidene) malononitrile ([(18)F]FDDNP) and to assess the influence of age ...

Last Updated: 14 Jun 2011

Go To URL
Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome.
 

Author(s): Jerzy Wegiel, Wojciech Kaczmarski, Madhabi Barua, Izabela Kuchna, Krzysztof Nowicki, Kuo-Chiang Wang, Jarek Wegiel, Shuang Ma Yang, Janusz Frackowiak, Bozena Mazur-Kolecka, Wayne P Silverman, Barry Reisberg, Isabel Monteiro, Mony de Leon, Thomas Wisniewski, Arthur Dalton, Florence Lai, Yu-Wen Hwang, Tatyana Adayev, Fei Liu, Khalid Iqbal, Inge-Grundke Iqbal, Cheng-Xin Gong

Journal: J. Neuropathol. Exp. Neurol.. 2011 Jan;70(1):36-50.

 

Triplication of chromosome 21 in Down syndrome (DS) results in overexpression of the minibrain kinase/dual-specificity tyrosine phosphorylated and regulated kinase 1A gene (DYRK1A). DYRK1A phosphorylates cytoplasmic tau protein and appears in intraneuronal neurofibrillary tangles ...

Last Updated: 23 Feb 2011

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "TAU syndrome" returned 0 free, full-text review articles on human participants.

 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

The Pathogenesis of Terson Syndrome and the Role of CSF Tau / Amyloid-ß 40 and 42 in Patients With Aneurysmatic Subarachnoid Hemorrhage
 

Status: Recruiting

Condition Summary: Subarachnoid Hemorrhage; Terson Syndrome; CSF-proteines

 

Last Updated: 29 Apr 2014

Go to URL
Glucose Metabolic, Amyloid, and Tau Brain Imaging in Down Syndrome and Dementia
 

Status: Recruiting

Condition Summary: Down Syndrome; Alzheimer's Disease

 

Last Updated: 23 Dec 2009

Go to URL
Tau Imaging of Chronic Traumatic Encephalopathy
 

Status: Not yet recruiting

Condition Summary: Chronic Traumatic Encephalopathy.

 

Last Updated: 17 Jul 2014

Go to URL